zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - szisztémás antibakteriális szerek, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. figyelembe kell venni hivatalos útmutató a megfelelő használatára az antibakteriális szerek.
betahistine dihydrochloride stada 16 mg tabletta
stada arzneimittel ag - betahistine dihidroklorid -
noradrenaline kabi 1 mg/ml koncentrátum oldatos infúzióhoz
fresenius kabi hungary kft. - noradrenalin -
kapidin 10 mg filmtabletta
zentiva, k.s. (csehország) - lercanidipine hydrochloride -
pioglitazone/metformin genepharm 15 mg/850 mg filmtabletta
genepharm s.a. - pioglitazone; metformin hydrochloride -
sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - hiv fertőzések - vírusellenes szerek szisztémás alkalmazásra - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 és 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 és 5.
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukémia, mieloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
saxagliptin pharos 2,5 mg filmtabletta
pharos pharmaceutical oriented services ltd. - saxagliptin hydrochloride -
saxagliptin pharos 5 mg filmtabletta
pharos pharmaceutical oriented services ltd. - saxagliptin hydrochloride -
0,9% sodium chloride inj. usp-baxter infúzió 250 ml
baxter (hungary) kft. - nátrium-klorid -